tiprankstipranks
Advertisement
Advertisement

INMB Stock Latest News

INmune Bio’s MINDFuL trial presented as succesful example in Alzheimer’s
The FlyINmune Bio’s MINDFuL trial presented as succesful example in Alzheimer’s
8d ago
INMB
INmune Bio upgraded to Buy from Neutral at Lucid Capital
PremiumThe Fly
INmune Bio upgraded to Buy from Neutral at Lucid Capital
16d ago
INMB
Inmune Bio Completes Early INKmune Trial in Advanced Prostate Cancer: What Investors Should Watch Next
PremiumCompany Announcements
Inmune Bio Completes Early INKmune Trial in Advanced Prostate Cancer: What Investors Should Watch Next
28d ago
INMB
INmune Bio Highlights CORDStrom RDEB Program and IP Strength
PremiumCompany Announcements
INmune Bio Highlights CORDStrom RDEB Program and IP Strength
28d ago
8K
INMB
INmune Bio Advances XPro Toward Registrational Alzheimer’s Study
PremiumCompany Announcements
INmune Bio Advances XPro Toward Registrational Alzheimer’s Study
1M ago
8K
INMB
INmune Bio to Present New CORDStrom Phase III Data
PremiumCompany AnnouncementsINmune Bio to Present New CORDStrom Phase III Data
1M ago
8K
INMB
INmune Bio Advances CORDStrom Toward Rare Disease Commercialization
Premium
Company Announcements
INmune Bio Advances CORDStrom Toward Rare Disease Commercialization
1M ago
8K
INMB
INmune Bio: Biomarker-Driven Alzheimer’s Trial Design and Pipeline Catalysts Underpin Buy Rating
Premium
Ratings
INmune Bio: Biomarker-Driven Alzheimer’s Trial Design and Pipeline Catalysts Underpin Buy Rating
1M ago
INMB
INmune Bio announces FDA alignment on phase 2b/3 registration pathway
PremiumThe Fly
INmune Bio announces FDA alignment on phase 2b/3 registration pathway
1M ago
INMB
INmune Bio submits pre-submission package for CORDStrom with MHRA
PremiumThe Fly
INmune Bio submits pre-submission package for CORDStrom with MHRA
2M ago
INMB
INmune Bio: Undervalued Pipeline with 2026 Clinical and Regulatory Catalysts Driving Buy Rating
PremiumRatings
INmune Bio: Undervalued Pipeline with 2026 Clinical and Regulatory Catalysts Driving Buy Rating
2M ago
INMB
INmune Bio outlines 2026 regulatory path in shareholder letter
PremiumCompany Announcements
INmune Bio outlines 2026 regulatory path in shareholder letter
2M ago
8K
INMB
INmune Bio CEO says ‘well positioned for continued execution’
PremiumThe FlyINmune Bio CEO says ‘well positioned for continued execution’
2M ago
INMB
Inmune Bio Amends April 2024 Investor Warrants
Premium
Company Announcements
Inmune Bio Amends April 2024 Investor Warrants
3M ago
8K
INMB
INmune Bio Establishes $65 Million At-The-Market Offering
Premium
Company Announcements
INmune Bio Establishes $65 Million At-The-Market Offering
3M ago
8K
INMB
Inmune Bio Ends Sales Agreement with RBC and BTIG
PremiumCompany Announcements
Inmune Bio Ends Sales Agreement with RBC and BTIG
4M ago
8K
INMB
Inmune Bio Unveils Promising Alzheimer’s Trial Data
PremiumCompany Announcements
Inmune Bio Unveils Promising Alzheimer’s Trial Data
4M ago
8K
INMB
INmune Bio publishes study on INmune’s CORDStrom platform
PremiumThe Fly
INmune Bio publishes study on INmune’s CORDStrom platform
4M ago
INMB
Inmune Bio Updates Executive Employment Agreements
PremiumCompany Announcements
Inmune Bio Updates Executive Employment Agreements
4M ago
8K
INMB
INmune Bio announces neuroimaging data from Phase 2 MINDFuL trial
PremiumThe FlyINmune Bio announces neuroimaging data from Phase 2 MINDFuL trial
4M ago
INMB
Inmune Bio Announces New Executive Employment Agreements
Premium
Company Announcements
Inmune Bio Announces New Executive Employment Agreements
4M ago
8K
INMB
INmune Bio Approves Option Repricing Proposal
Premium
Company Announcements
INmune Bio Approves Option Repricing Proposal
4M ago
8K
INMB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >